NAKACHI Kohei | National Cancer Center Hospital East
スポンサーリンク
概要
関連著者
-
Okusaka T
Hepatobiliary And Pancreatic Oncology Division National Cancer Center Hospital
-
FURUSE Junji
National Cancer Center Hospital East
-
NAKACHI Kohei
National Cancer Center Hospital East
-
Okusaka Takuji
Hepatobiliary And Pancreatic Oncology And Hepatobiliary And Pancreatic Surgery Divisions National Cancer Center Hospital
-
Ozawa Shogo
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
UENO Hideki
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
-
Yamashita Tatsuya
金沢大学 大学院医学系研究科恒常性制御学講座
-
Kojiro Masamichi
日本肝癌研究会
-
Ioka Tatsuya
国立がんセンター中央病院
-
Ioka Tatsuya
Pancreatic And Hepatobiliary Oncology Division Osaka Medical Center For Cancer And Cardiovascular Di
-
Kaneko Shuichi
Departments Of Gastroenterology Graduate School Of Medical Sciences Kanazawa University
-
Ueno Hideki
国立医薬品食品衛生研究所 薬物応答予測プロジェクト
-
Furuse Junji
Hepatobiliary And Pancreatic Oncology Division National Cancer Center Hospital East
-
Kojiro Masamichi
Department Of Gastroenterology And Hepatology Kinki University School Of Medicine
-
Okusaka Takuji
Hepatobiliary And Pancreatic Oncology Division National Cancer Center Hospital
-
Ozawa Shogo
National Institute Of Health Sciences
-
FUNAKOSHI AKIHIRO
National Kyushu Cancer Center
-
IGUCHI HARUO
National Kyushu Cancer Center
-
KOJIRO Masamichi
The Liver Cancer Study Group of Japan
-
Yamao Kenji
Aichi Cancer Center Hospital
-
Funakoshi Akihiro
National Epilepsy Center Shizuoka Medical Institute Of Neurological Disorders
-
Yamashita Tatsuya
Department Of Gastroenterology Kanazawa University
-
Yamashita Tatsuya
Department Of Gastroenterology And Nephrology Kanazawa University Graduate School Of Medical Science
-
Ueno Hideki
Hepatobiliary And Pancreatic Oncology Division National Cancer Center Hospital
-
Ozawa Shogo
Project Team For Pharmacogenetics National Inst. Of Health Sciences
-
Kaneko Shuichi
Department Of Cancer Gene Regulation Kanazawa University
-
Kudo Masatoshi
Department Of Gastroenterology And Hepatology Kinki University School Of Medicine
-
Ueshima Kazuomi
Departments Of Gastroenterology And Hepatology Kinki University School Of Medicine
-
Ohkawa Shinichi
Division Of Hepatobiliary And Pancreatic Oncology Kanagawa Cancer Center Hospital
-
Kitahara Shuichiro
Departments Of Gastroenterology Graduate School Of Medical Sciences Kanazawa University
-
Ito Tetsuhide
Kyushu Univ. Fukuoka Jpn
-
NAKACHI Kohei
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East
-
Ueshima Kazuomi
Department Of Gastroenterology And Hepatology Kinki University School Of Medicine
-
Ueno Hideki
Hepatobiliary And Pancreatic Oncology Division
-
Nakamori Shoji
National Hospital Organization Osaka National Hospital
-
Ioka Tatsuya
Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Ioka Tatsuya
Department Of Hepatobiliary And Pancreatic Oncology Osaka Medical Center For Cancer And Cardiovascul
-
OKUSAKA Takuji
National Cancer Center Hospital
-
OHKAWA Shinichi
Kanagawa Cancer Center Hospital
-
BOKU Narikazu
Shizuoka Cancer Center
-
KOMATSU Yoshito
Hokkaido University Hospital
-
NAKAGAWA Kazuhiko
Kinki University School of Medicine
-
Yamashita Tatsuya
Department Of Gastroenterology Kanazawa University Graduate School Of Medical Science
-
Kaneko Shuichi
Department Of Gastroenterology Kanazawa University Hospital
-
Ito Tetsuhide
Kyushu University
-
Iguchi Haruo
National Hospital Organization Shikoku Cancer Center
-
Kudo Masatoshi
Department Of Gastroenterology And Hepatology Kinki University Faculty Of Medicine
-
Nakagawa Kazuhiko
Kinki University Faculty Of Medicine Medical Oncology
-
Yamashita Tatsuya
Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science
-
Kudo Masatoshi
Department of Clinical Molecular Medicine, Division of Diabetes, Digestive and Kidney Diseases
著作論文
- Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma
- Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer